Literature DB >> 35384443

[Osteoporosis: diagnostics and treatment].

Ulla Stumpf1, Moritz Kraus1, Roland Ladurner2, Carl Neuerburg1, Wolfgang Böcker3.   

Abstract

Osteoporosis is the most common systemic skeletal disease worldwide. Its consequences have a substantial impact on the quality of life of patients and increases the overall morbidity and mortality. Standardized diagnostic procedures and treatment recommendations have been available for years as German and international (S3) guidelines. Nevertheless, there is a considerable gap in the diagnosis and adequate treatment of osteoporosis, especially in Germany. The aim is to detect the disease at an early stage and to establish a specific and consistent treatment of osteoporosis. In this way the quality of life and independence of those affected can be maintained over a long period. In the acute and permanent treatment of manifest osteoporosis, surgeons, orthopedic and trauma surgeons play a key role.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Antiresorptive drugs; Diagnostics; Hyperparathyroidism; Osteoanabolic treatment; Secondary osteoporosis

Year:  2022        PMID: 35384443     DOI: 10.1007/s00104-022-01595-x

Source DB:  PubMed          Journal:  Chirurgie (Heidelb)        ISSN: 2731-6971


  10 in total

1.  [Osteoporosis].

Authors:  C Neuerburg; U Stumpf; W Mutschler
Journal:  Unfallchirurg       Date:  2015-11       Impact factor: 1.000

2.  One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study.

Authors:  E Michael Lewiecki; Rajani V Dinavahi; Marise Lazaretti-Castro; Peter R Ebeling; Jonathan D Adachi; Akimitsu Miyauchi; Evelien Gielen; Cassandra E Milmont; Cesar Libanati; Andreas Grauer
Journal:  J Bone Miner Res       Date:  2018-12-03       Impact factor: 6.741

3.  [Do we need new care structures in trauma surgery? : Altered needs of an aging society].

Authors:  Eric Hesse
Journal:  Unfallchirurg       Date:  2019-10       Impact factor: 1.000

4.  The epidemiology of osteoporosis--Bone Evaluation Study (BEST): an analysis of routine health insurance data.

Authors:  Peyman Hadji; Silvia Klein; Holger Gothe; Bertram Häussler; Thomas Kless; Torsten Schmidt; Thomas Steinle; Frank Verheyen; Roland Linder
Journal:  Dtsch Arztebl Int       Date:  2013-01-25       Impact factor: 5.594

5.  Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.

Authors:  W Brozek; B Reichardt; J Zwerina; H P Dimai; K Klaushofer; E Zwettler
Journal:  Osteoporos Int       Date:  2015-11-17       Impact factor: 4.507

6.  Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.

Authors:  P Hadji; N Papaioannou; E Gielen; M Feudjo Tepie; E Zhang; I Frieling; P Geusens; P Makras; H Resch; G Möller; L Kalouche-Khalil; A Fahrleitner-Pammer
Journal:  Osteoporos Int       Date:  2015-05-28       Impact factor: 4.507

7.  Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.

Authors:  A Fahrleitner-Pammer; N Papaioannou; E Gielen; M Feudjo Tepie; C Toffis; I Frieling; P Geusens; P Makras; E Boschitsch; J Callens; A D Anastasilakis; C Niedhart; H Resch; L Kalouche-Khalil; P Hadji
Journal:  Arch Osteoporos       Date:  2017-06-22       Impact factor: 2.617

8.  Reduced Awareness for Osteoporosis in Distal Radius Fracture Patients Compared to Patients with Proximal Femur Fractures.

Authors:  Alexander Martin Keppler; Moritz Kraus; Matthias Blaschke; Nicole Thomasser; Christian Kammerlander; Wolfgang Böcker; Carl Neuerburg; Ulla Cordula Stumpf
Journal:  J Clin Med       Date:  2021-02-19       Impact factor: 4.241

9.  The Short Physical Performance Battery (SPPB): A Quick and Useful Tool for Fall Risk Stratification Among Older Primary Care Patients.

Authors:  Sarah A Welch; Rachel E Ward; Marla K Beauchamp; Suzanne G Leveille; Thomas Travison; Jonathan F Bean
Journal:  J Am Med Dir Assoc       Date:  2020-11-13       Impact factor: 7.802

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.